{"id":3797,"date":"2022-03-11T00:00:53","date_gmt":"2022-03-10T15:00:53","guid":{"rendered":"https:\/\/hbio.jp\/news\/?p=3797"},"modified":"2022-08-12T12:08:57","modified_gmt":"2022-08-12T03:08:57","slug":"%e3%80%90press-release%e3%80%91hirotsu-bioscience-inc-has-become-a-partner-firm-of-i2-jp-launched-by-astrazeneca","status":"publish","type":"post","link":"https:\/\/hbio.jp\/news\/en\/2022\/03\/11\/%e3%80%90press-release%e3%80%91hirotsu-bioscience-inc-has-become-a-partner-firm-of-i2-jp-launched-by-astrazeneca\/","title":{"rendered":"HIROTSU BIOSCIENCE, INC. has become a partner firm of i2.JP,  launched by AstraZeneca"},"content":{"rendered":"<p class=\"wp-block-paragraph\"> We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect parties such as start-ups, healthcare professionals, local governments, academia and private companies.  i2.JP aims to joinly solve problems in the healthcare sector and to come up with practical and optimal solutions. <\/p>","protected":false},"excerpt":{"rendered":"<p>We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect partie [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"3797","footnotes":""},"categories":[3],"tags":[],"class_list":["post-3797","post","type-post","status-publish","format-standard","hentry","category-press-release","en-US"],"acf":[],"_links":{"self":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/3797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/comments?post=3797"}],"version-history":[{"count":2,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/3797\/revisions"}],"predecessor-version":[{"id":3941,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/3797\/revisions\/3941"}],"wp:attachment":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/media?parent=3797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/categories?post=3797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/tags?post=3797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}